The ethanolic extract of Kaempferia parviflora reduces ischaemic injury in rat isolated hearts

J Ethnopharmacol. 2011 Sep 1;137(1):184-91. doi: 10.1016/j.jep.2011.05.004. Epub 2011 May 10.

Abstract

Aims of the study: The ethanolic extract of Kaempferia parviflora (KPE) has been reported to contain a range of flavonoids and to enhance endothelial synthesis of NO. We investigated the vascular relaxant, antioxidant and cardioprotective activities of KPE.

Materials and methods: Vascular function was assessed in rat aortic rings and superoxide generation determined using lucigenin enhanced chemiluminescence. Ischaemia and reperfusion were induced in rat isolated, perfused hearts.

Results: KPE caused vasorelaxation (R(max) 102 ± 2%), which was partly inhibited by removal of the endothelium (R(max) 91 ± 1%) or by N(G)-nitro-l-arginine (L-NNA, R(max) 83 ± 3%) or 1H-[1,2,4] oxadiazolo[4,3-a]quinoxaline-1-one (ODQ, R(max) 80 ± 2%). In addition KPE caused concentration-dependent inhibition of the contractile response to exogenous Ca(2+). KPE (10(-3)M) also significantly inhibited superoxide radical generation induced by of xanthine/xanthine oxidase (2.3 ± 0.4% of control) to a similar extent to the xanthine oxidase inhibitor allopurinol (10(-4)M, 1.6 ± 0.5%) or by rat isolated aorta in the presence of NADPH (30.0 ± 6.3% of control) similarly to the NADPH oxidase inhibitor diphenyliodonium (5 × 10(-6)M, 23.1 ± 5.6%). In the presence of oxidant stress generated by pyrogallol endothelium-dependent relaxation of rat aortic rings was impaired (ACh R(max) control 99 ± 1%; pyrogallol 44 ± 5%), an effect that was significantly reduced by KPE (10(-4)M, ACh R(max) 82 ± 4%). In addition, KPE was found to attenuate the ventricular dysfunction caused by 20 min global ischaemia and 30 min reperfusion (I/R) in rat isolated hearts (dP/dt IR 1016 ± 242, IR+KPE 2238±233 mm Hg/s).

Conclusion: KPE is an effective vasodilator and antioxidant that is able to prevent myocardial ischaemia-reperfusion injury. We suggest that KPE may be useful as an adjunct to thrombolytic therapy in the management of reperfusion injury.

MeSH terms

  • Animals
  • Antioxidants / chemistry
  • Antioxidants / isolation & purification
  • Antioxidants / pharmacology*
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology
  • Enzyme Inhibitors / pharmacology
  • Ethanol / chemistry*
  • Guanylate Cyclase / antagonists & inhibitors
  • Guanylate Cyclase / metabolism
  • In Vitro Techniques
  • Male
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / physiopathology
  • Myocardial Reperfusion Injury / prevention & control*
  • Myocardium / metabolism
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Perfusion
  • Plant Exudates / chemistry
  • Plant Exudates / isolation & purification
  • Plant Exudates / pharmacology*
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Soluble Guanylyl Cyclase
  • Solvents / chemistry*
  • Superoxides / metabolism
  • Vasodilation / drug effects
  • Vasodilator Agents / chemistry
  • Vasodilator Agents / isolation & purification
  • Vasodilator Agents / pharmacology*
  • Ventricular Function, Left / drug effects
  • Xanthine Oxidase / antagonists & inhibitors
  • Xanthine Oxidase / metabolism
  • Zingiberaceae* / chemistry

Substances

  • Antioxidants
  • Enzyme Inhibitors
  • Plant Exudates
  • Receptors, Cytoplasmic and Nuclear
  • Solvents
  • Vasodilator Agents
  • Superoxides
  • Ethanol
  • Nitric Oxide Synthase
  • Prostaglandin-Endoperoxide Synthases
  • Xanthine Oxidase
  • NADPH Oxidases
  • Guanylate Cyclase
  • Soluble Guanylyl Cyclase